Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study (Q44596602)
Jump to navigation
Jump to search
scientific article published on 11 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study |
scientific article published on 11 January 2012 |
Statements
1 reference
Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study (English)
1 reference
Kerstin Albertsson-Wikland
1 reference
Niko Speybroeck
1 reference
Anita Hokken-Koelega
1 reference
Birgit Borgström
1 reference
Marc Maes
1 reference
Jean-Claude Carel
1 reference
Séverine Henrard
1 reference
Muriel Thomas
1 reference
Gladys Zandwijken
1 reference
11 January 2012
1 reference
1 reference
Identifiers
1 reference